Nuclea, Clark University to Start Proteomics, Metabolomics Center | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics developer Nuclea Biotechnologies and Clark University will establish a new center to use proteomics and metabolomics methods in conducting biomarker research focused on cancer, Nuclea said yesterday.

The Pittsfield, Mass.-based firm will expand an ongoing partnership with Clark to establish a new Proteomic and Metabolomic Center on the university's campus in Worcester.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.